about
The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parametersOncological Safety of Lipofilling in Patients with Breast Cancer: A Meta-analysis and Update on Clinical Practice.The role of death-associated protein 3 in apoptosis, anoikis and human cancerTowards optimal management of the axilla in the context of a positive sentinel node biopsy in early breast cancerEmerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine.The clinical implications of poly implant prothèse breast implants: an overview.Breast Auto-Augmentation: A Versatile Method of Breast Rehabilitation-A Retrospective Series of 107 Procedures.Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: A systematic review and meta-analysis.The interaction between DAP1 and autophagy in the context of human carcinogenesis.Breast lipofilling: a review of current practiceDo online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysis.Evidence of an autocrine role for leptin and leptin receptor in human breast cancer.Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?Guanine nucleotide binding protein β 1: a novel transduction protein with a possible role in human breast cancer.The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancer.Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer.A Comparison of the Performance of EndoPredict Clinical and NHS PREDICT in 120 Patients Treated for ER-positive Breast Cancer.The mRNA expression of DAP1 in human breast cancer: correlation with clinicopathological parameters.Nipple-sparing mastectomy using a hemi-periareolar incision with or without minimal medial-lateral extensions; clinical outcome and patient satisfaction: A single centre prospective observational study.The evolving role of pre-pectoral ADM-assisted implant-based immediate breast reconstruction following skin-sparing mastectomy.The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer.Comment on prognostic and therapeutic implications of mTORC2 and rictor expression in human breast cancer.The Evolving Role of Pre-pectoral ADM-assisted Approach in Implant-based Immediate Breast Reconstruction Following Conservative Mastectomy: An Overview of the Literature and Description of TechniqueCorrelation of and Stem Cell Markers in the Context of Human Breast CancerA Study of the Relation Between Mastectomy Specimen Weight and Volume With Implant Size in Oncoplastic ReconstructionOutcomes of endoscopic sphenopalatine artery ligation for epistaxis: a five-year series from a single institutionChemoprevention of Prostate Cancer by Natural Agents: Evidence from Molecular and Epidemiological StudiesBisphenol A: A Concise Review of Literature and a Discussion of Health and Regulatory Implications
P50
Q28258443-AC7637D3-DF03-494E-A211-E85C81059D00Q30245353-54608C14-B46E-4957-9078-15352DF581A7Q34043792-4D6AA130-0E1A-43AC-8748-FDF8A5CAE729Q34657647-FA2125C8-D498-4D64-987F-374472282A5AQ34657656-82ECEA99-2F83-4402-B968-661F7E813CDFQ34980613-CE808D94-623F-468B-A1B4-79C3C2C3ECEAQ35883679-AE7B3073-A1D5-4C69-AC96-927D96894F16Q36824707-21E4B587-4D0E-4C15-BCE8-A7F4BFB69277Q38176870-F85EEE49-268D-49C7-AD2F-BC309FBF76D1Q38387194-49ACB629-9614-4FAB-92AE-BB6BA22F9F23Q38721972-C58EA69A-B900-440B-AF51-7F8D73135709Q38988780-68CA0C91-1618-4A61-8120-E63ED695238EQ39242818-CA6E0325-57C7-4E68-984C-0D153C5E7EF6Q41611004-29C39C58-5658-4AC7-BBEE-CEC3D8877015Q45744204-B9E4163A-E37E-4524-93DD-052042B3C48CQ46028315-ECD8755D-CD75-4078-84B8-6DA943209560Q46085864-665D6C0E-E64E-4312-A075-657E8028ACC2Q46342520-7C86AF8D-87BB-460F-81D2-9940AC540E15Q47350388-9EEAB728-BDB9-4763-BA62-88C29E92E0D1Q47381708-716BE099-9BEC-4255-8857-D289E8217EAAQ47675842-00B811E1-8CA9-4F6E-96ED-673220A69246Q49346658-F13C8841-2E0A-45EE-AD0B-84CAC4FDA5B3Q53080649-B0FB9350-357E-4960-BCF0-9627341173F5Q54478497-BE1FCB08-E85E-47D7-B69C-164B4427FD5BQ57787406-D365F109-F9A1-4035-9AFE-CDFBC1D609A5Q64070586-A37B8715-BF51-45C2-B12A-83234C3CC3AEQ64232061-C62ED201-1755-4306-AEB3-A7CA92F29F31Q83498177-F88EC87C-1B7B-4094-B012-4F0E152BF876Q90387974-DD688FA9-8D43-4011-8280-FF7F625ECA2FQ93021843-C6F4E6E7-F22C-4A7D-94FE-A164357ECF7B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Umar Wazir
@ast
Umar Wazir
@en
Umar Wazir
@es
Umar Wazir
@sl
type
label
Umar Wazir
@ast
Umar Wazir
@en
Umar Wazir
@es
Umar Wazir
@sl
prefLabel
Umar Wazir
@ast
Umar Wazir
@en
Umar Wazir
@es
Umar Wazir
@sl
P1053
I-7557-2014
P106
P21
P31
P3829
P496
0000-0001-8979-692X